Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Henry

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
Nature Communications|December 22, 2017
The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmissionDanielle O Sambo, Min Lin, Anthony Owens, et al.
Sexually Transmitted Diseases|October 23, 2010
Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study)Erna Milunka Kojic, Susan Cu-Uvin, Lois Conley, et al.
The Journal of Infectious Diseases|August 14, 2015
Incidence and Predictors of Abnormal Anal Cytology Findings Among HIV-Infected Adults Receiving Contemporary Antiretroviral TherapyLois J Conley, Timothy J Bush, Teresa M Darragh, et al.
The Journal of Biological Chemistry|July 7, 2011
A conserved asparagine residue in transmembrane segment 1 (TM1) of serotonin transporter dictates chloride-coupled neurotransmitter transportL Keith Henry, Hideki Iwamoto, Julie R Field, et al.
Antiviral Therapy|November 1, 2012
Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the USKate Buchacz, Rose K Baker, Frank J Palella, et al.
British Journal of Pharmacology|June 7, 2017
Blockade of the 5-HT transporter contributes to the behavioural, neuronal and molecular effects of cocaineLinda D Simmler, Allison M J Anacker, Michael H Levin, et al.
The Lancet. HIV|July 1, 2021
Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trialOnyema Ogbuagu, Peter J Ruane, Daniel Podzamczer, et al.
Human Molecular Genetics|January 7, 2020
Taurine treatment of retinal degeneration and cardiomyopathy in a consanguineous family with SLC6A6 taurine transporter deficiencyMuhammad Ansar, Emmanuelle Ranza, Madhur Shetty, et al.
The Journal of Infectious Diseases|August 26, 2016
Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010Kate Buchacz, Bryan Lau, Yuezhou Jing, et al.
Open Forum Infectious Diseases|September 24, 2021
Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 StudyGraham H R Smith, W Keith Henry, Daniel Podzamczer, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Nature Communications|December 22, 2017
The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmissionDanielle O Sambo, Min Lin, Anthony Owens, et al.
Sexually Transmitted Diseases|October 23, 2010
Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study)Erna Milunka Kojic, Susan Cu-Uvin, Lois Conley, et al.
The Journal of Infectious Diseases|August 14, 2015
Incidence and Predictors of Abnormal Anal Cytology Findings Among HIV-Infected Adults Receiving Contemporary Antiretroviral TherapyLois J Conley, Timothy J Bush, Teresa M Darragh, et al.
The Journal of Biological Chemistry|July 7, 2011
A conserved asparagine residue in transmembrane segment 1 (TM1) of serotonin transporter dictates chloride-coupled neurotransmitter transportL Keith Henry, Hideki Iwamoto, Julie R Field, et al.
Antiviral Therapy|November 1, 2012
Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the USKate Buchacz, Rose K Baker, Frank J Palella, et al.
British Journal of Pharmacology|June 7, 2017
Blockade of the 5-HT transporter contributes to the behavioural, neuronal and molecular effects of cocaineLinda D Simmler, Allison M J Anacker, Michael H Levin, et al.
The Lancet. HIV|July 1, 2021
Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trialOnyema Ogbuagu, Peter J Ruane, Daniel Podzamczer, et al.
Human Molecular Genetics|January 7, 2020
Taurine treatment of retinal degeneration and cardiomyopathy in a consanguineous family with SLC6A6 taurine transporter deficiencyMuhammad Ansar, Emmanuelle Ranza, Madhur Shetty, et al.
The Journal of Infectious Diseases|August 26, 2016
Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010Kate Buchacz, Bryan Lau, Yuezhou Jing, et al.
Open Forum Infectious Diseases|September 24, 2021
Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 StudyGraham H R Smith, W Keith Henry, Daniel Podzamczer, et al.
Pageof 14